Guidelines for Therapeutic Drug Monitoring of Cardiovascular Drugs Clinical Use of Blood Drug Concentration Monitoring (JCS 2015) - Digest Version
Circ J
.
2017 Mar 24;81(4):581-612.
doi: 10.1253/circj.CJ-66-0138.
Epub 2017 Mar 9.
Authors
Kazutaka Aonuma
,
Tsuyoshi Shiga
,
Hirotsugu Atarashi
,
Kosuke Doki
,
Hirotoshi Echizen
,
Nobuhisa Hagiwara
,
Junichi Hasegawa
,
Hideharu Hayashi
,
Kenzo Hirao
,
Fukiko Ichida
,
Takanori Ikeda
,
Yorinobu Maeda
,
Naoki Matsumoto
,
Toshiyuki Sakaeda
,
Wataru Shimizu
,
Mitsuru Sugawara
,
Kyoichi Totsuka
,
Yoshimasa Tsuchishita
,
Kazuyuki Ueno
,
Eiichi Watanabe
,
Masayuki Hashiguchi
,
Sumio Hirata
,
Hidefumi Kasai
,
Yoshiaki Matsumoto
,
Akihiko Nogami
,
Yukio Sekiguchi
,
Tokuko Shinohara
,
Atsushi Sugiyama
,
Naokata Sumitomo
,
Atsushi Suzuki
,
Naohiko Takahashi
,
Eiji Yukawa
,
Masato Homma
,
Minoru Horie
,
Hiroshi Inoue
,
Hiroshi Ito
,
Takanori Miura
,
Tohru Ohe
,
Kimikazu Shinozaki
,
Kazuhiko Tanaka
;
Japanese Circulation Society and the Japanese Society of Therapeutic Drug Monitoring Joint Working Group
PMID:
28302953
DOI:
10.1253/circj.CJ-66-0138
No abstract available
MeSH terms
Cardiovascular Agents / blood*
Drug Monitoring / methods*
Guidelines as Topic*
Humans
Substances
Cardiovascular Agents